Filing Flows › 10x Genomics (TXG) › Stock forecast & fair value
10x Genomics (TXG) stock forecast and price target
10x Genomics (TXG) trades at $59.28. 14 analysts' median price target is $69.00 (+16%), from $50.00 to $100.00.
10x Genomics' latest quarter
10x Genomics, Q3 2026: revenue $151M (+1% year over year), operating margin -10.7%, net loss $19.4M, operating cash flow $15.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for TXG stock?
The median of 14 analysts' 12-month targets is $69.00, +16% from $59.28; the range is $50.00 to $100.00. The average rating is buy.
Does 10x Genomics usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is TXG stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.